Carvedilol vs Durvalumab

## Carvedilol vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Carvedilol** and **Durvalumab**.

## Mechanism of Action

**Carvedilol**: Non-selective beta-blocker with alpha-1 blocking activity.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Carvedilol — 7-10 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Carvedilol — C24H26N2O4; Durvalumab — N/A.

**Molecular Weight**: Carvedilol — 406.4740 g/mol; Durvalumab — N/A.

**Type**: Carvedilol — Small molecule; Durvalumab — Antibody.